Related Experiment Videos
Unknown primary melanoma. Summary This summary is machine-generated. Unknown primary melanoma, while rare, has a prognosis similar to typical melanoma. Aggressive surgical treatment for regional lymph node metastasis shows promising long-term survival for some patients.
You might also read
Related Articles Articles linked to this work by shared authors, journal, and citation graph.
All12 Same author6 Same journal6
Area of Science:
Oncology Dermatology Surgical Pathology Background:
Melanoma of unknown primary (MUP) is a rare clinical presentation. Identifying MUP is crucial for appropriate staging and treatment. Purpose of the Study:
To evaluate the clinical characteristics and outcomes of patients with unknown primary melanoma. To assess the efficacy of aggressive surgical management for MUP. Main Methods:
Retrospective review of 230 melanoma patients over 8 years. Analysis of 12 patients diagnosed with unknown primary melanoma. Surgical management (lymphadenectomy) followed by adjuvant therapy for regional lymph node metastasis.
Related Experiment Videos
5.2% of melanoma patients had unknown primary lesions.
Nine patients presented with regional lymph node metastasis, one with parotid gland involvement, and two with disseminated disease.
Four patients with single lymph node metastasis remain disease-free 4-6 years post-treatment.
One patient with multiple groin metastases survived 8 years post-surgery.
Five patients with multiple regional lymph node metastases died within 16 months to 3 years.
Both patients with disseminated MUP died within one month. Conclusions:
Unknown primary melanoma prognosis appears comparable to melanoma of known primary at similar stages. Aggressive surgical intervention, including lymphadenectomy, is warranted for MUP with regional lymph node metastasis. Further research into optimal adjuvant therapies for MUP is indicated.